![J.P. Steve Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 335 720 $ au 31/07/2026
J.P.
Steve Hsu is the founder of Genovior Biotech Corp., founded in 2015, serving as Chairman & Chief Executive Officer since 2015.
Former job includes Chief Executive Officer at Polaris Group from 2023 to 2025.
Education includes a doctorate from the Massachusetts Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
POLARIS GROUP 0,11% | 23/03/2025 | 1 000 000 ( 0,11% ) | 335 720 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Genovior Biotech Corp.
 Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Directeur Général | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| POLARIS GROUP | Directeur Général | 24/12/2025 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Polaris Group
 Polaris Group BiotechnologyHealth Technology Engages in research and development of protein drugs to treat cancer and other debilitating diseases in humans | Health Technology |
Genovior Biotech Corp.
Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
